A Phase II study of q4w carboplatin plus nab-paclitaxel in chemo-naive patients with squamous cell lung cancer (OSAKA-LCSG1302)
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin
- Indications Lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms OSAKA-LCSG1302
- 31 Mar 2017 Status changed from recruiting to discontinued.
- 03 Oct 2013 New trial record